CIK 0001770069
- Emerging growth company
MapLight Therapeutics, Inc.
Sign in to watch- Ticker
- MPLT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 832163243
- Phone
- +1 617-984-6300
- Business address
- 800 CHESAPEAKE DRIVE, REDWOOD CITY, CA, 94063
- Former names
- Alvarado Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,256,232
- in 7 filings, $193K under 10b5-1 plans
Net −$1,256,232. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Kroeger Christopher A. −$595K Chief Executive Officer sold 6% of stake
- Hanson Kristopher −$266K General Counsel sold 17% of stake
- Foff Erin Pennock −$124K Chief Medical Officer sold 5% of stake
- Kreitzer Anatol −$96K Chief Discovery Officer sold 7% of stake
- Lillie James Woodruff −$93K Chief Scientific Officer sold 5% of stake
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-15 | Foff Erin Pennock Chief Medical Officer | Sale | −15,355 | $8.08 | $124K | 296,906 |
| 2026-08-17 | Foff Erin Pennock Chief Medical Officer | Grant or award | +13,360 | 312,261 | ||
| 2026-08-17 | Foff Erin Pennock Chief Medical Officer | Grant or award · Employee Stock Option (right to buy) | +54,240 | 54,240 | ||
| 2026-07-17 | Foff Erin Pennock Chief Medical Officer | Sale 10b5-1 | −3,656 | $37.90 | $139K | 298,901 |
| 2026-07-16 | Foff Erin Pennock Chief Medical Officer | Sale 10b5-1 | −9,163 | $36.46 | $334K | 308,441 |
| 2026-07-16 | Foff Erin Pennock Chief Medical Officer | Sale 10b5-1 | −5,865 | $37.26 | $219K | 302,576 |
| 2026-07-16 | Foff Erin Pennock Chief Medical Officer | Sale 10b5-1 | −19 | $37.96 | $721 | 302,557 |
| 2026-07-15 | Foff Erin Pennock Chief Medical Officer | Sale 10b5-1 | −7,155 | $36.16 | $259K | 338,904 |
| 2026-07-15 | Foff Erin Pennock Chief Medical Officer | Sale 10b5-1 | −7,845 | $37.04 | $291K | 331,059 |
| 2026-07-15 | Foff Erin Pennock Chief Medical Officer | Sale 10b5-1 | −4,465 | $36.00 | $161K | 326,594 |
| 2026-07-15 | Foff Erin Pennock Chief Medical Officer | Sale 10b5-1 | −8,972 | $36.99 | $332K | 317,622 |
| 2026-07-15 | Foff Erin Pennock Chief Medical Officer | Sale 10b5-1 | −18 | $37.54 | $676 | 317,604 |
| 2026-05-07 | Foff Erin Pennock Chief Medical Officer | Sale 10b5-1 | −4,321 | $28.52 | $123K | 346,176 |
| 2026-05-07 | Foff Erin Pennock Chief Medical Officer | Sale 10b5-1 | −117 | $29.10 | $3K | 346,059 |
| 2026-05-06 | Foff Erin Pennock Chief Medical Officer | Sale 10b5-1 | −8,152 | $28.04 | $229K | 366,397 |
| 2026-05-06 | Foff Erin Pennock Chief Medical Officer | Sale 10b5-1 | −15,900 | $29.13 | $463K | 350,497 |
| 2026-05-05 | Foff Erin Pennock Chief Medical Officer | Sale 10b5-1 | −9,645 | $28.12 | $271K | 375,480 |
| 2026-05-05 | Foff Erin Pennock Chief Medical Officer | Sale 10b5-1 | −931 | $29.00 | $27K | 374,549 |
| 2026-05-04 | Foff Erin Pennock Chief Medical Officer | Sale 10b5-1 | −9,180 | $27.50 | $252K | 391,597 |
| 2026-05-04 | Foff Erin Pennock Chief Medical Officer | Sale 10b5-1 | −5,460 | $28.37 | $155K | 386,137 |
Page 1 of 2 · 30 trades